BONE METASTASES
Clinical trials for BONE METASTASES explained in plain language.
Never miss a new study
Get alerted when new BONE METASTASES trials appear
Sign up with your email to follow new studies for BONE METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a shot every 12 weeks be as good as every 4 weeks for cancer bone health?
Disease control OngoingThis phase 3 trial tests whether giving denosumab every 12 weeks is as effective as the standard every 4 weeks at preventing bone complications (like fractures or need for radiation) in people with metastatic breast or prostate cancer that has spread to the bone. About 1380 parti…
Matched conditions: BONE METASTASES
Phase: PHASE3 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New drug targets tough cancers in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called 9-ING-41, which blocks a protein (GSK-3β) that helps cancers grow. It is given alone or with chemotherapy to 350 adults with advanced or hard-to-treat cancers like pancreatic, breast, lung, or bone cancer. The goal is to see if the dru…
Matched conditions: BONE METASTASES
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Blood thinner showdown: aspirin vs. heparin for cancer surgery patients
Disease control ENROLLING_BY_INVITATIONThis study compares two common blood thinners, aspirin and low molecular weight heparin (LMWH), to prevent dangerous blood clots after orthopedic surgery for cancer. About 2,868 adults having surgery on the pelvis or leg for bone metastases or sarcoma will be enrolled. The goal i…
Matched conditions: BONE METASTASES
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a drug boost radiation for prostate cancer?
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation therapy helps control prostate cancer that has come back in a few spots (up to 5). About 96 men with hormone-sensitive prostate cancer will receive either radiation alone or radiation plus durvalumab for 12…
Matched conditions: BONE METASTASES
Phase: PHASE2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Precision radiation may extend time without cancer growth in Bone-Only metastases
Disease control OngoingThis study tests whether adding a high-dose, precise type of radiation called SBRT to standard treatments (like hormone therapy or chemotherapy) can delay cancer progression in people with solid tumors that have spread to 1 to 5 spots in the bones. It includes adults up to age 75…
Matched conditions: BONE METASTASES
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis small pilot study tested whether a special PET scan using a radioactive tracer can predict how well patients with advanced HER2-positive breast cancer respond to the drug ado-trastuzumab emtansine (T-DM1). Ten women with cancer that had spread to other parts of the body rece…
Matched conditions: BONE METASTASES
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
Sound waves vs. bone pain: new combo could replace radiation
Symptom relief OngoingThis study tests if using focused ultrasound (MR-HIFU) alone or with standard radiation can better relieve bone pain caused by cancer that has spread to the bones. About 216 adults with painful bone metastases will receive either ultrasound, ultrasound plus radiation, or radiatio…
Matched conditions: BONE METASTASES
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 17, 2026 01:59 UTC
-
Exercise after radiation: a new hope for bone metastasis pain?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a structured, supervised exercise program is safe and doable for people who have had radiation for painful bone metastases (cancer that spread to bones, but not the spine). About 20 adults with good mobility and a life expectancy of at least 6 months w…
Matched conditions: BONE METASTASES
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Can we predict survival more accurately for bone metastasis patients?
Knowledge-focused OngoingThis study aims to improve how doctors estimate survival for people with cancer that has spread to their bones. Researchers will combine the doctor's assessment with the patient's own health report to create a more accurate prediction. The goal is to help guide treatment decision…
Matched conditions: BONE METASTASES
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC
-
Can a PET scan predict bone cancer treatment success?
Knowledge-focused OngoingThis study looks at whether a special PET scan can help doctors see how well hormone therapy is working in breast cancer that has spread to the bones. About 75 adults with ER+ breast cancer and bone metastases will get a PET scan before starting new hormone treatment, then again …
Matched conditions: BONE METASTASES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC